Price Alert

Context Therapeutics Inc. (CNTX)

NASDAQ: CNTX · Real-Time Price · USD

0.78

0.04 (5.94%)

At close: Aug 15, 2025, 12:12 PM

Context Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	83.52M	89.35M	94.43M	84.8M	101.54M	10.09M	14.45M	21.68M	25.14M	29.77M	35.5M	39.43M	42.92M	45.73M	49.64M	419.15K	1.28M	1.66M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.39K	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	200K	n/a	n/a	n/a	n/a	n/a	24K	26.19K	32.75K	39.31K	67.75K	24K	n/a	1.82M	1.42M	580.72K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.43M	3.38M	3.47M	1.27M	1.16M	949.49K	1.6M	1.29M	2.57M	2.12M	2.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	86.95M	92.73M	97.9M	86.07M	102.7M	11.04M	16.05M	22.97M	27.71M	31.89M	37.85M	41.94M	44.5M	46.86M	51.26M	437.53K	1.3M	1.67M
Property-Plant & Equipment	203.87K	234.66K	230.78K	259.03K	10.39K	12.96K	15.52K	18.09K	28.7K	54.27K	79.53K	104.51K	129.21K	151.47K	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	203.87K	234.66K	430.77K	259.03K	10.39K	12.96K	15.52K	18.09K	52.7K	80.45K	112.28K	143.83K	196.96K	175.47K	50.39K	1.82M	1.42M	580.72K
Total Assets	87.15M	92.97M	98.13M	86.33M	102.71M	11.05M	16.06M	22.99M	27.76M	31.97M	37.97M	42.08M	44.7M	47.03M	51.31M	2.26M	2.72M	2.25M
Account Payables	2.4M	1M	1.45M	1.03M	611.51K	2.05M	2.38M	1.83M	1.19M	1.21M	936.33K	1.49M	945.46K	454.83K	1.83M	3.08M	1.72M	1.89M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	114.98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	124.05K	96.4K
Other Current Liabilities	2.04M	315.05K	297.01K	717.16K	552.32K	13.7K	1.16M	2.14M	2.12M	1.74M	853.51K	547.08K	355.23K	752.35K	85.53K	n/a	n/a	n/a
Total Current Liabilities	4.56M	1.9M	2.75M	2.33M	1.6M	2.61M	4.19M	4.6M	3.76M	3.23M	3.21M	4.01M	3.04M	1.61M	3.03M	4.41M	3.96M	3.34M
Long-Term Debt	52.33K	82.61K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27.66K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	21.06M	21.06M	16.36M
Total Long-Term Liabilities	52.33K	82.61K	112.06K	140.2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.97K	31.67K	n/a	21.06M	21.06M	16.39M
Total Liabilities	4.61M	1.98M	2.86M	2.47M	1.6M	2.61M	4.19M	4.6M	3.76M	3.23M	3.21M	4.01M	3.05M	1.64M	3.03M	25.47M	25.02M	19.73M
Total Debt	167.32K	193.71K	219.38K	244.36K	n/a	n/a	n/a	n/a	7.97K	31.67K	55.08K	78.2K	101.03K	123.58K	n/a	n/a	124.05K	124.05K
Common Stock	89.7K	89.7K	89.7K	75K	75K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	15.97K	348.00	342.00	33.00
Retained Earnings	-108.18M	-99.36M	-94.78M	-91.44M	-73.98M	-71.72M	-68.05M	-61.28M	-55.41M	-50.4M	-44.09M	-40.53M	-36.68M	-32.69M	-29.25M	-26.16M	-24.72M	-19.69M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	82.54M	90.98M	95.27M	83.86M	101.1M	8.44M	11.87M	18.38M	24M	28.73M	34.76M	38.07M	41.65M	45.39M	48.27M	-23.21M	-22.3M	-17.48M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.39K	n/a	n/a	n/a